Other and unspecified coagulation defects

D3_COAGDEFNAS

blood coagulation disease: A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D68.8, D68.9 Hospital discharge: ICD-9 — 2869 Hospital discharge: ICD-8 — 2869 Cause of death: ICD-10 — D68.8, D68.9 Cause of death: ICD-9 — 2869 Cause of death: ICD-8 — 2869 2 out of 7 registries used, show all original rules.	2031
4. Check minimum number of events None	2031
5. Include endpoints None	2031
6. Filter based on genotype QC (FinnGen only)	1948

Control definitions (FinnGen only)

Control exclude: D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	D3_COAGDEFNAS
CONTROL_EXCLUDE	D3_COAGDEF_PURPUR_HAEMORRHAGIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D68[8-9]
HD_ICD_9	2869
HD_ICD_8	2869
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D68[8-9]
COD_ICD_9	2869
COD_ICD_8	2869
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified coagulation defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11374	7399	3902
Only index persons	10454	6997	3457
Unadjusted period prevalence (%)
Whole population	0.18	0.21	0.11
Only index persons	0.22	0.26	0.13
Median age at first event (years)
Whole population	41.80	37.06	50.90
Only index persons	41.92	37.10	51.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1948	1353	595
Unadjusted period prevalence (%)	0.42	0.48	0.27
Median age at first event (years)	46.95	42.48	57.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2031: Matched controls
20310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

13.1

315.3

323

290

D68.8

ICD-10 Finland

Other specified coagulation defects

5254.2

307.7

1655

B01AB05

ATC

enoxaparin; parenteral

8.6

307.7

1361

3881

B01AA03

ATC

warfarin; systemic

11.5

307.7

953

1449

B01AB04

ATC

dalteparin; parenteral

11.9

307.7

407

419

D68.9

ICD-10 Finland

Coagulation defect, unspecified

1589.1

307.7

485

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

19.1

307.7

288

174

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

10.3

286.3

350

404

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

12.3

259.0

272

252

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

36.3

255.7

161

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.5

217.8

507

1153

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

17.7

204.6

170

104

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

807.6

154.5

150

K94

ICPC

Phlebitis/thrombophlebitis

15.3

151.3

135

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

14.7

139.2

127

Z2221

NOMESCO Finland

Medical doctor

3.1

131.4

869

3935

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

13.3

128.3

124

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

6.2

124.2

226

400

XF400

NOMESCO Finland

ECG with 12 standard connections

3.7

122.3

477

1557

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

49.0

122.0

R4110

NOMESCO Finland

Physiotherapy

3.0

113.5

771

3488

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.3

105.5

490

1773

D68.0

ICD-10 Finland

Von Willebrand disease

534.4

103.6

102

K99

ICPC

Cardiovascular disease other

9.2

101.3

126

145

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.3

99.2

175

299

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

10.8

91.0

100

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

90.8

1028

5847

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.2

90.8

263

688

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

84.3

397

1432

Z3226

NOMESCO Finland

Physiotherapist

2.8

83.5

522

2206

ZXD10

NOMESCO Finland

Scheduled procedure

2.4

82.5

931

5224

Z3231

NOMESCO Finland

Registered nurse

2.5

80.6

707

3527

B01AB10

ATC

tinzaparin; parenteral

3.5

79.4

313

1010

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

9.0

77.1

113

I87.0

ICD-10 Finland

Postthrombotic syndrome

40.1

76.9

ZXE00

NOMESCO Finland

One hour or less

2.3

76.0

979

5762

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

17.1

75.7

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

75.4

856

4766

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

9.5

74.7

K93

ICPC

Pulmonary embolism

13.7

69.2

I26

ICD-10 Finland

Pulmonary embolism

13.1

68.5

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

68.4

541

2541

R06.0

ICD-10 Finland

Dyspnoea

2.4

68.2

643

3271

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

3.0

66.2

338

1266

N02AX02

ATC

tramadol; systemic, rectal

2.2

65.2

948

5759

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

63.0

638

3331

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

11.0

62.1

M79.6

ICD-10 Finland

Pain in limb

2.1

61.0

991

6239

B01AX05

ATC

fondaparinux; parenteral

15.1

59.8

K78

ICPC

Atrial fibrillation/flutter

3.9

56.9

181

502

WX892

NOMESCO Finland

Monitored bed care

3.4

56.5

217

683

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.3

56.3

228

742

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

54.3

640

3520

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.8

49.9

279

1089

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.6

49.8

173

509

R60.0

ICD-10 Finland

Localized oedema

2.8

49.7

284

1121

R4120

NOMESCO Finland

Occupational therapy

3.3

49.5

198

638

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.5

49.3

177

532

AA1AD

NOMESCO Finland

CT of head and brain

2.2

49.2

548

2928

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

49.2

661

3798

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

49.2

231

819

ZXD05

NOMESCO Finland

Urgent procedure

2.0

48.7

739

4436

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

18.1

48.2

126

Kela drug reimbursment

Chronic coagulation defects

+∞

48.1

Z71.8

ICD-10 Finland

Other specified counselling

2.0

47.5

765

4683

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

45.8

257

1003

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

45.2

367

1711

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

45.0

337

1515

C03CA01

ATC

furosemide; systemic

2.2

44.8

498

2647

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

44.8

247

955

H02AB07

ATC

prednisone; oral

2.5

44.2

329

1474

ZX120

NOMESCO Finland

Intravenous

2.8

43.2

241

936

B01AF02

ATC

apixaban; oral

2.8

43.2

247

972

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

43.1

310

1366

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

10.9

42.7

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

10.0

41.9

Z2446

NOMESCO Finland

Social worker

3.0

41.4

203

735

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.5

40.4

WX002

NOMESCO Finland

Sedation and analgesia

2.2

39.9

419

2166

B01AF01

ATC

rivaroxaban; oral

2.6

39.8

261

1098

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

39.5

846

5609

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

39.5

490

2699

L04AA06

ATC

mycophenolic acid; systemic

5.8

38.9

128

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.1

38.4

172

591

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

36.9

133

400

3AC01, ,

NOMESCO Finland

8.2

36.8

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.4

35.6

136

424

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

35.5

144

466

L17

ICPC

Foot/toe symptom/complaint

1.9

35.5

614

3775

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

5.1

35.4

151

N03AX16

ATC

[U] pregabalin

2.0

35.3

492

2813

XF404

NOMESCO Finland

Ambulatory ECG

2.7

34.4

199

785

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.3

34.3

212

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.7

34.2

115

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

34.0

932

6569

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

10.7

34.0

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

342.8

34.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

33.6

460

2606

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

39.0

33.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

33.4

901

6314

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.0

33.3

159

566

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

32.7

294

1419

H02AB06

ATC

prednisolone; systemic

1.7

32.4

956

6853

N02BE01

ATC

paracetamol; systemic, rectal

2.4

32.3

1812

15803

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

32.0

549

3348

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

6.3

31.9

J01MA12

ATC

levofloxacin; systemic

2.1

31.8

368

1959

ZXA00

NOMESCO Finland

Right side

1.9

31.0

509

3056

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

30.5

622

3990

ZXA05

NOMESCO Finland

Left side

1.9

30.5

463

2707

P01BA02

ATC

hydroxychloroquine; oral

2.5

30.4

205

871

L04AX01

ATC

azathioprine; systemic

3.2

29.9

122

396

315

Kela drug reimbursment

Clopidogrel

8.1

29.9

C07AB07

ATC

bisoprolol; oral

1.7

29.9

829

5802

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

29.8

584

3697

Z01.7

ICD-10 Finland

Laboratory examination

2.1

29.8

342

1813

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

29.7

219

969

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

29.2

142

510

K29

ICPC

Cardiovascular sympt/complt other

3.7

29.0

268

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

28.9

252

1199

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.6

28.7

270

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

28.0

136

488

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

27.9

408

2349

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.8

27.5

235

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

27.4

144

539

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

27.4

187

798

A02BC02

ATC

pantoprazole; systemic

1.7

27.2

1319

10602

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

27.0

167

680

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.1

26.8

114

379

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.8

26.5

128

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

2.2

26.1

250

1233

R50.9

ICD-10 Finland

Fever, unspecified

2.0

25.5

326

1788

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

25.5

107

353

K92.1

ICD-10 Finland

Melaena

3.1

24.8

109

370

A02BC01

ATC

omeprazole; systemic

1.7

24.7

534

3450

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

24.6

146

582

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

24.6

293

1567

XF620

NOMESCO Finland

Examination of circulation with color method

9.5

24.4

R51.80

ICD-10 Finland

Headache

1.9

24.4

384

2255

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.5

24.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.3

24.3

154

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

24.3

243

1217

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.3

24.3

150

L28

ICPC

Limited function/disability (L)

2.0

24.2

311

1708

J01MA02

ATC

ciprofloxacin; systemic

1.7

24.1

716

5028

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

24.1

191

870

WX402

NOMESCO Finland

General anaesthesia

1.8

23.4

450

2804

TK800

NOMESCO Finland

Hemodialysis

4.6

23.4

121

J01DB01

ATC

cefalexin; oral

1.9

23.4

1690

14787

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

23.2

217

1058

ZXD35

NOMESCO Finland

Usual procedure

3.4

23.0

245

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

22.9

394

2373

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

22.8

742

5315

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

22.7

164

717

ZXA10

NOMESCO Finland

Bilateral

1.9

22.6

348

2025

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

22.4

198

943

R04.0

ICD-10 Finland

Epistaxis

2.5

22.4

147

615

A46

ICD-10 Finland

Erysipelas

2.0

22.2

256

1350

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

22.2

145

605

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

22.0

236

1212

J01MA14

ATC

moxifloxacin; systemic

2.2

22.0

186

871

S16

ICPC

Bruise/contusion

3.5

21.9

218

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

18.6

21.7

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

21.7

135

551

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

21.6

102

360

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

7.6

21.2

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.1

21.2

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

21.2

660

4658

K84

ICPC

Heart disease other

4.0

21.1

153

127

Kela drug reimbursment

Transplant complication

4.9

21.1

N96

ICD-10 Finland

Habitual aborter

6.0

20.9

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.9

20.9

103

373

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

20.8

293

1655

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

20.8

284

1588

R42

ICD-10 Finland

Dizziness and giddiness

1.7

20.7

416

2616

J01FF01

ATC

clindamycin; systemic

1.7

20.6

533

3585

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

20.5

268

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

42.1

20.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

20.2

319

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

27.3

20.0

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

17.5

20.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

20.0

160

731

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

6.0

20.0

A28

ICPC

Limited function/disability NOS

1.9

20.0

261

1436

R03DC03

ATC

montelukast; oral

1.8

20.0

366

2239

C10AA05

ATC

atorvastatin; oral

1.6

19.8

639

4533

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

19.8

220

1144

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

19.6

148

659

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

19.6

142

621

Z35.1

ICD-10 Finland

Supervision of pregnancy with history of abortive outcome

6.7

19.6

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.9

19.5

153

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

19.4

395

2488

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

19.3

134

575

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

19.3

333

2001

L04AD02

ATC

tacrolimus; systemic

5.6

19.2

Z2445

NOMESCO Finland

Psychologist

2.6

19.1

111

438

28698

ICD-8 Finland

Coagulation defects, Other

+∞

18.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

18.7

163

771

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

18.7

122

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.2

18.7

118

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

18.6

157

734

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

18.6

111

444

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.7

18.4

370

A02BC05

ATC

esomeprazole; systemic

1.5

18.3

761

5693

L14

ICPC

Leg/thigh symptom/complaint

2.2

18.2

163

780

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

18.1

123

523

S97

ICPC

Chronic ulcer skin

2.6

18.1

109

438

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

18.0

106

421

XF402

NOMESCO Finland

ECG with work load test

2.1

17.9

184

928

A08

ICPC

Swelling

2.6

17.8

103

405

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.6

17.8

104

411

B83

ICPC

Purpura/coagulation defect

+∞

17.7

B02AA02

ATC

tranexamic acid; systemic

1.8

17.7

330

2024

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

17.6

463

3110

R53

ICD-10 Finland

Malaise and fatigue

1.6

17.6

484

3288

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

17.4

529

3682

A11CC03

ATC

alfacalcidol; systemic

3.7

17.4

152

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

17.3

335

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.5

17.2

167

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

17.2

441

2942

J01FA06

ATC

roxithromycin; oral

1.5

17.2

761

5751

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

17.2

153

730

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

17.2

375

2400

O28.0

ICD-10 Finland

Abnormal haematological finding on antenatal screening of mother

31.7

17.0

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

17.0

344

JN4BD

NOMESCO Finland

Extensive body CT

2.1

16.9

178

906

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

16.9

102

410

L04AD01

ATC

ciclosporin; systemic

3.8

16.9

141

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

16.8

164

812

R03BA02

ATC

budesonide; inhalant

1.7

16.8

368

2358

D66

ICD-10 Finland

Hereditary factor VIII deficiency

+∞

16.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

16.6

1444

12496

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

16.6

108

450

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.9

16.5

125

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

16.5

161

797

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

16.3

1553

17018

R5110, ,

SPAT

2.3

16.2

123

549

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

16.1

127

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

16.1

151

736

K22

ICPC

Risk factor cardiovascular disease

2.4

16.0

108

458

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

16.0

108

458

R4130

NOMESCO Finland

Speech therapy

3.2

15.9

196

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

15.8

161

809

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

15.8

126

575

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

15.7

157

783

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

15.7

141

675

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

15.7

173

896

D68.4

ICD-10 Finland

Acquired coagulation factor deficiency

+∞

15.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

15.6

1082

8890

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

85.8

15.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

15.5

470

3254

UJF32

NOMESCO Finland

Coloscopy

1.6

15.5

440

3000

R02

ICPC

Shortness of breath/dyspnoea

1.8

15.5

236

1360

M05BA04

ATC

alendronic acid; oral

2.2

15.4

132

620

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

15.4

185

987

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

15.4

225

1281

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

15.4

380

2506

O36.4

ICD-10 Finland

Maternal care for intrauterine death

6.1

15.1

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

15.1

251

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

15.0

392

2619

R06AE07

ATC

cetirizine; oral

1.5

15.0

890

7080

R52.9

ICD-10 Finland

Pain, unspecified

1.9

14.9

196

1078

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

14.9

123

570

J01AA02

ATC

doxycycline; systemic

1.5

14.8

1474

12929

R4190

NOMESCO Finland

Nutritional therapy

2.5

14.8

363

A07AA02

ATC

nystatin; oral

2.3

14.8

109

481

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

14.8

222

1274

H53.4

ICD-10 Finland

Visual field defects

3.5

14.7

145

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

4.8

14.7

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

13.3

14.7

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.2

14.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

14.6

196

N02AA05

ATC

oxycodone; systemic

1.8

14.6

262

1584

D68

ICD-10 Finland

Other coagulation defects

80.7

14.6

Z31.5

ICD-10 Finland

Genetic counselling

2.1

14.5

137

670

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

14.4

167

880

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

14.4

214

PH2AE, ,

SPAT

3.2

14.3

173

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.1

14.2

194

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

14.2

1034

8509

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.7

14.1

ZXD20

NOMESCO Finland

Day surgery

1.7

14.1

253

1529

WW200

NOMESCO Finland

Immunization

3.0

14.1

211

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.9

356

2362

D01

ICPC

Abdominal pain/cramps general

1.7

13.9

248

1497

PA6AD

NOMESCO Finland

CT of neck arteries

3.1

13.9

197

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

13.9

122

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.1

13.8

R03AC02

ATC

salbutamol; inhalant

1.4

13.8

1094

9124

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

13.8

609

4553

D69.0

ICD-10 Finland

Allergic purpura

23.9

13.8

WW500

NOMESCO Finland

Blood transfusion

2.7

13.8

287

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

6.3

13.7

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.9

13.7

231

L04AA01

ATC

[U] ciclosporin

4.2

13.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.4

13.6

X58

ICD-10 Finland

Exposure to other specified factors

1.7

13.6

278

1742

D69.1

ICD-10 Finland

Qualitative platelet defects

140.9

13.5

J01MA06

ATC

norfloxacin; oral

1.7

13.4

245

1487

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.3

13.4

149

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

13.4

174

952

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.0

13.4

196

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

13.3

257

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.7

13.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.6

13.3

R55

ICD-10 Finland

Syncope and collapse

1.9

13.3

181

1006

N30.0

ICD-10 Finland

Acute cystitis

1.6

13.3

311

2017

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

13.3

420

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

13.3

360

2420

B01AE07

ATC

dabigatran etexilate; oral

2.9

13.3

224

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

13.3

181

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.2

732

5707

A97

ICPC

No disease

1.6

13.2

334

2209

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

13.1

204

TAB00

NOMESCO Finland

Lumbar puncture

2.3

13.1

101

455

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

13.0

319

2093

E0000UV, ,

ATC

1.4

13.0

796

6319

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

12.9

257

1598

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

12.9

109

510

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.8

12.8

105

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

12.8

272

1720

N03AF02

ATC

oxcarbazepine; oral

2.6

12.8

292

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

12.8

129

EB1AA, ,

SPAT

2.0

12.7

146

767

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

12.7

205

1202

M04AA01

ATC

allopurinol; systemic

1.9

12.6

173

964

J20

ICD-10 Finland

Acute bronchitis

1.8

12.6

200

1166

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

+∞

12.5

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

12.5

394

M25.5

ICD-10 Finland

Pain in joint

1.4

12.5

624

4764

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

12.4

160

873

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

5.7

12.4

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

12.4

285

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

12.3

168

934

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

12.3

113

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

12.3

334

2244

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.8

12.2

229

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

12.1

134

695

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

12.1

139

731

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

12.0

151

817

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

12.0

165

919

K27

ICPC

Fear cardiovascular disease other

5.3

12.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

12.0

231

P01AB01

ATC

metronidazole; oral, rectal

1.4

12.0

769

6128

G47.3

ICD-10 Finland

Sleep apnoea

1.5

12.0

382

2660

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.9

12.0

187

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.7

12.0

H02AB04

ATC

methylprednisolone; systemic

1.7

11.9

258

1638

A01

ICPC

Pain general/multiple sites

1.8

11.9

171

967

R03BB04

ATC

tiotropium bromide; inhalant

1.9

11.9

160

886

PHD99

NOMESCO Finland

Resection of other vein

2.1

11.9

113

554

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

11.9

523

3890

K90

ICPC

Stroke/cerebrovascular accident

3.0

11.9

177

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

11.8

172

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

11.8

175

999

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

11.8

136

716

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

11.7

439

3161

-60

ICPC

Result test/procedure

2.1

11.7

108

524

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

2.3

11.7

380

PA2AD

NOMESCO Finland

CT angiography of brain

4.6

11.7

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.9

11.7

WX872

NOMESCO Finland

Intensive care

2.3

11.6

368

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

11.6

181

1049

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

11.6

177

1019

R06AX27

ATC

desloratadine; oral

1.4

11.6

599

4589

A99

ICPC

Disease/condition unspecnature/site

1.8

11.6

170

968

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

11.6

409

2910

I81

ICD-10 Finland

Portal vein thrombosis

10.1

11.5

J01FA10

ATC

azithromycin; systemic

1.4

11.5

1157

9918

B99

ICPC

Blood/lymph/spleen disease other

9.3

11.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

11.5

402

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.6

11.5

104

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

11.5

449

3261

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.4

11.5

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

11.4

213

1300

RD210, ,

NOMESCO Finland

3.2

11.4

144

G44.2

ICD-10 Finland

Tension-type headache

1.6

11.4

283

1860

H02AB09

ATC

hydrocortisone; systemic

2.8

11.4

198

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

2.1

11.3

107

523

C01CA24

ATC

epinephrine; parenteral

1.9

11.3

150

826

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

11.3

104

503

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

11.3

204

205

Kela drug reimbursment

Chronic hypertension

1.6

11.3

335

2294

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

11.3

156

872

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

11.2

312

2104

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.5

11.2

299

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.5

11.2

269

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

11.2

182

1068

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

11.2

101

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

2.7

11.2

234

W84

ICPC

Pregnancy high risk

2.2

11.2

433

C10AA01

ATC

simvastatin; oral

1.4

11.1

549

4166

NHQ40

NOMESCO Finland

Amputation of toe

4.2

11.1

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

11.0

164

937

J01CA04

ATC

amoxicillin; systemic

1.5

11.0

1633

14915

A07DA03

ATC

loperamide; oral

2.7

11.0

219

R04.2

ICD-10 Finland

Haemoptysis

2.7

11.0

219

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

4.8

11.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

11.0

187

1113

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.1

10.9

153

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

10.9

229

1441

WX722

NOMESCO Finland

PEEP

2.3

10.9

359

C03DA01

ATC

spironolactone; oral

1.8

10.9

176

1032

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.2

10.8

R11

ICD-10 Finland

Nausea and vomiting

1.8

10.7

165

952

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

10.7

453

J45

ICD-10 Finland

Asthma

1.7

10.7

199

1214

D07AB08

ATC

desonide; topical

1.7

10.7

206

1269

R31

ICD-10 Finland

Unspecified haematuria

1.9

10.6

147

821

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

10.6

251

1628

SPAT1229

SPAT

Assessment of need for aid

2.0

10.6

114

585

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.8

10.6

K60

ICPC

Cardiovascular, Result test/procedure

5.3

10.6

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

10.6

189

N03AX09

ATC

lamotrigine; oral

2.0

10.6

114

586

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.4

10.6

110

S21

ICPC

Skin texture symptom/complaint

1.6

10.5

245

1583

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.3

10.5

346

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.8

10.5

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

14.3

10.5

2869X

ICD-9 Finland

Coagulation defects, Other and unspecified coagulation defects

+∞

10.4

D06

ICPC

Abdominal pain localized other

1.8

10.4

168

984

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

16.1

10.3

E66.8

ICD-10 Finland

Other obesity

1.9

10.3

122

647

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

12.1

10.3

R2110

NOMESCO Finland

Giving the first information

1.9

10.3

142

793

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.9

10.3

A11

ICPC

Chest pain NOS

1.9

10.2

136

750

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.5

10.2

360

2554

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

2.4

10.2

294

JN4AD

NOMESCO Finland

Body CT examination

1.8

10.2

152

870

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

10.2

779

6348

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

10.1

160

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

10.1

188

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

5.3

10.1

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.6

10.1

J01DC02

ATC

cefuroxime; systemic

2.0

10.1

115

603

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

10.1

547

4208

XMA22

NOMESCO Finland

General examination of pregnant woman

1.8

10.1

143

806

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

10.1

393

2845

C08CA05

ATC

nifedipine; systemic

2.1

10.0

486

M54.5

ICD-10 Finland

Low back pain

1.4

10.0

683

5458

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

10.0

150

859

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

3.7

10.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.4

9.9

292

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

9.9

115

A02BA02

ATC

ranitidine; systemic

1.5

9.9

304

2095

J01DA06

ATC

[U] cefuroxime

1.6

9.9

263

1755

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

9.8

202

1264

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

9.8

171

1023

M35.1

ICD-10 Finland

Other overlap syndromes

8.1

9.8

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.3

9.8

318

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

20.1

9.8

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

9.8

105

539

D45

ICD-10 Finland

Polycythaemia vera

4.6

9.8

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.7

9.8

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.3

9.7

111

A12AA04

ATC

calcium carbonate; oral

3.7

9.7

Z94.0

ICD-10 Finland

Kidney transplant status

4.2

9.6

TK810

NOMESCO Finland

Hemofiltration

7.8

9.6

N20.0

ICD-10 Finland

Calculus of kidney

3.0

9.6

138

WX213

NOMESCO Finland

Lower leg blockade

5.0

9.6

J05AB11

ATC

valaciclovir; oral

1.6

9.6

262

1759

XX9XW, ,

NOMESCO Finland

4.5

9.6

WX110, ,

SPAT

1.9

9.5

125

687

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

9.5

368

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

9.5

116

623

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

9.5

161

957

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.8

9.5

161

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

9.5

273

R81

ICPC

Pneumonia

2.4

9.4

267

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.1

9.4

J02AC01

ATC

fluconazole; systemic

1.4

9.4

790

6505

Z92.1

ICD-10 Finland

Personal history of long-term (current) use of anticoagulants

30.2

9.4

WW400

NOMESCO Finland

Plasmaferesis

17.6

9.4

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

9.4

457

S29

ICPC

Skin symptom/complaint other

1.5

9.4

323

2277

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

9.4

430

I82.0

ICD-10 Finland

Budd-Chiari syndrome

+∞

9.4

2BD06, ,

NOMESCO Finland

+∞

9.4

N05CF01

ATC

zopiclone; oral

1.4

9.4

520

4008

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

3.5

9.4

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

9.3

451

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

9.3

179

R07.3

ICD-10 Finland

Other chest pain

1.7

9.3

182

1124

N06AB04

ATC

citalopram; systemic

1.5

9.3

372

2703

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

9.3

109

578

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.2

9.3

372

L01BA01

ATC

methotrexate; systemic

2.3

9.2

301

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

9.2

227

1485

RS221, ,

NOMESCO Finland

3.2

9.2

115

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

9.2

212

1366

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

9.2

198

ZZA00

NOMESCO Finland

Split skin graft

2.7

9.2

181

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

9.1

137

785

N03AX12

ATC

[U] gabapentin; oral

1.5

9.1

278

1909

A60

ICPC

General and Unspecified, Result test/procedure

2.1

9.1

394

N18.0

ICD-10 Finland

End-stage renal disease

4.3

9.1

I50.0

ICD-10 Finland

Congestive heart failure

2.1

9.1

402

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.8

9.1

WX890

NOMESCO Finland

Intesive care monitoring

4.6

9.1

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

9.0

143

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.9

9.0

143

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

9.0

506

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.8

9.0

160

K91

ICPC

Cerebrovascular disease

4.1

9.0

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.5

9.0

343

2468

B01AC04

ATC

clopidogrel; oral

1.6

8.9

208

1343

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.9

232

1538

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

8.9

184

K92

ICPC

Atherosclerosis/periph vascular dis

4.4

8.9

ZX108

NOMESCO Finland

Inhalation

4.9

8.8

G72.9

ICD-10 Finland

Myopathy, unspecified

4.5

8.8

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

8.8

401

2980

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

8.8

434

RS220, ,

NOMESCO Finland

3.2

8.8

108

L12

ICPC

Hand/finger symptom/complaint

1.5

8.8

296

2078

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.2

8.7

J01DA01

ATC

[U] cefalexin

1.3

8.7

1154

10118

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

8.7

141

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

8.6

159

967

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

8.6

126

717

A91

ICPC

Abnormal result investigation NOS

2.0

8.6

445

N05BA04

ATC

oxazepam; oral

1.4

8.6

457

3492

I82

ICD-10 Finland

Other venous embolism and thrombosis

11.6

8.6

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

8.5

225

1496

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.5

322

2314

KH1AD

NOMESCO Finland

CT of urinary organs

2.3

8.4

262

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

8.4

250

L02

ICPC

Back symptom/complaint

1.6

8.4

194

1251

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.7

8.4

172

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

8.4

180

1140

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.9

8.4

102

548

D69.4

ICD-10 Finland

Other primary thrombocytopenia

+∞

8.3

M10.9

ICD-10 Finland

Gout, unspecified

2.0

8.3

450

F29

ICPC

Eye symptom/complaint other

1.7

8.3

167

1039

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

8.3

173

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

10.8

8.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

8.3

106

579

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

8.3

254

1747

N03AG01

ATC

valproic acid; systemic, rectal

1.8

8.3

112

623

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

8.2

123

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

8.2

133

780

C08CA01

ATC

amlodipine; oral

1.4

8.2

524

4121

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

1.9

8.2

105

574

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

8.2

259

1793

H05AA02

ATC

teriparatide; parenteral

7.6

8.2

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

8.1

213

1414

M01AH02

ATC

rofecoxib; oral

1.6

8.1

185

1188

XQ800

NOMESCO Finland

Prick test

1.7

8.1

157

967

R52.0

ICD-10 Finland

Acute pain

2.1

8.1

345

GD1LA

NOMESCO Finland

3.3

8.1

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.8

8.1

H53.2

ICD-10 Finland

Diplopia

2.3

8.1

274

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

8.0

491

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

8.0

442

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

8.9

8.0

N02AC04

ATC

dextropropoxyphene; oral

2.4

8.0

218

M79.1

ICD-10 Finland

Myalgia

1.5

8.0

284

2011

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

8.0

261

1818

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

8.0

194

1266

318

Kela drug reimbursment

Teriparatide

7.3

8.0

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

7.9

327

2384

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

7.9

276

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

7.9

868

7376

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

7.9

369

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

7.9

124

722

280

Kela drug reimbursment

Clopidogrel

3.6

7.9

L01XX05

ATC

hydroxycarbamide; oral

3.6

7.9

R05

ICPC

Cough

1.4

7.8

434

3331

C10AA07

ATC

rosuvastatin; oral

1.4

7.8

461

3574

N05BA01

ATC

diazepam; systemic, rectal

1.5

7.8

217

1459

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.7

7.8

159

993

R01AD09

ATC

mometasone; nasal

1.3

7.8

885

7548

S06.0

ICD-10 Finland

Concussion

1.6

7.8

186

1208

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.4

7.8

I74.2

ICD-10 Finland

Embolism and thrombosis of arteries of upper extremities

10.8

7.8

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

7.0

7.8

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

7.7

183

1187

I82.1

ICD-10 Finland

Thrombophlebitis migrans

45.1

7.7

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.9

7.7

117

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

6.4

7.7

ZXE90

NOMESCO Finland

More than 22 hours

6.4

7.7

M05BX04

ATC

denosumab; parenteral

2.0

7.7

407

XX9XE

NOMESCO Finland

Other ultrasound examination

3.9

7.7

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

7.7

442

J01FA09

ATC

clarithromycin; systemic

1.3

7.7

571

4587

R03AC03

ATC

terbutaline; inhalant

1.5

7.7

246

1706

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

7.7

235

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.7

215

1450

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

4.5

7.6

L05

ICPC

Flank/axilla symptom/complaint

1.8

7.6

108

609

I74.8

ICD-10 Finland

Embolism and thrombosis of other arteries

18.4

7.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

7.6

230

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

7.6

314

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

11.9

7.6

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

7.6

197

1306

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.1

7.6

R83

ICPC

Respiratory infection other

1.3

7.5

530

4221

I63

ICD-10 Finland

Cerebral infarction

6.2

7.5

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

7.5

194

1284

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.8

7.5

130

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

7.5

296

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

7.5

377

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.3

7.5

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

7.5

343

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

7.5

104

584

S18

ICPC

Laceration/cut

1.3

7.5

745

6236

M03BX02

ATC

tizanidine; oral

1.3

7.4

1172

10413

N06AA09

ATC

amitriptyline; systemic

1.7

7.4

150

935

W19

ICD-10 Finland

Unspecified fall

1.6

7.4

159

1006

L29

ICPC

Musculoskeletal sympt/complt other

1.7

7.4

143

881

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.1

7.4

M02AA07

ATC

piroxicam; topical

1.3

7.4

556

4471

A07AA09

ATC

vancomycin; oral

3.4

7.4

J01MA01

ATC

ofloxacin; systemic

1.7

7.4

126

751

6BA02, ,

NOMESCO Finland

7.7

7.4

ZXE80

NOMESCO Finland

More than 18 and less than 21 hours

13.4

7.4

I27.0

ICD-10 Finland

Primary pulmonary hypertension

13.4

7.4

R13

ICD-10 Finland

Dysphagia

1.8

7.4

111

638

C08CA02

ATC

felodipine; oral

1.7

7.3

121

714

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

7.3

158

1001

R1260

NOMESCO Finland

Evaluation of communicative skills

2.9

7.3

115

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.2

7.3

253

N06AX12

ATC

bupropion; oral

1.6

7.3

152

955

C09AA05

ATC

ramipril; oral

1.4

7.3

328

2427

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

7.3

O991, D688,

ICD-10 Finland

+∞

7.3

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

9.4

7.3

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

7.3

230

1591

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.2

7.3

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

7.2

183

1205

R03BA05

ATC

fluticasone; inhalant

1.4

7.2

325

2405

N03AX14

ATC

levetiracetam; systemic

2.3

7.2

229

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

7.2

389

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

7.2

242

UJH02

NOMESCO Finland

Anoscopy

2.0

7.2

348

WX320

NOMESCO Finland

Spinalanesthesy

1.4

7.2

394

3015

R52.2

ICD-10 Finland

Other chronic pain

2.0

7.2

355

SBB10

NOMESCO Finland

Dental impressions

1.7

7.2

132

803

L15

ICPC

Knee symptom/complaint

1.4

7.2

388

2963

RS230, ,

NOMESCO Finland

4.5

7.2

L04AX03

ATC

methotrexate; systemic

1.6

7.2

168

1087

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

7.2

397

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

7.1

114

667

A06AD11

ATC

lactulose; oral

1.5

7.1

196

1316

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

6.6

7.1

L01

ICPC

Neck symptom/complaint

1.4

7.1

282

2040

R06.4

ICD-10 Finland

Hyperventilation

2.7

7.1

134

WX610

NOMESCO Finland

Patient controlled analgesia

3.8

7.1

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

12.1

7.1

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

12.1

7.1

R07.1

ICD-10 Finland

Chest pain on breathing

2.9

7.1

112

I87.9

ICD-10 Finland

Disorder of vein, unspecified

8.8

7.0

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

7.0

192

1287

I72.8

ICD-10 Finland

Aneurysm and dissection of other specified arteries

10.1

7.0

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.1

7.0

ZX112

NOMESCO Finland

Subcutaneous

2.6

7.0

158

R05

ICD-10 Finland

Cough

1.4

7.0

368

2795

R03BB01

ATC

ipratropium bromide; inhalant

2.3

7.0

232

K63.5

ICD-10 Finland

Polyp of colon

2.8

7.0

118

R4120, ,

SPAT

4.2

7.0

ZY010

NOMESCO Finland

Hospital outpatient

1.8

7.0

109

633

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.9

7.0

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.9

7.0

D07AC01

ATC

betamethasone; topical

1.3

7.0

612

5023

S20.2

ICD-10 Finland

Contusion of thorax

1.9

7.0

458

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

7.0

113

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.6

7.0

156

999

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.0

6.9

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.0

6.9

A12BA01

ATC

potassium chloride; oral

2.3

6.9

227

N05CF02

ATC

zolpidem; oral

1.4

6.9

304

2240

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

6.9

246

1743

M32

ICD-10 Finland

Systemic lupus erythematosus

13.8

6.9

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

6.9

222

1542

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.9

596

4882

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

6.9

396

V03AE01

ATC

polystyrene sulfonate; oral

3.6

6.9

XCK00

NOMESCO Finland

Perimetry

1.9

6.9

482

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

6.9

114

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

6.8

526

RS222, ,

NOMESCO Finland

3.3

6.8

SPAT1336

SPAT

Request for examination

2.1

6.8

321

-49

ICPC

Other preventive procedure

4.1

6.8

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.8

6.8

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.8

6.8

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

6.8

335

Z3232

NOMESCO Finland

Midwife

1.5

6.8

190

1280

J47

ICD-10 Finland

Bronchiectasis

2.9

6.8

109

N06AX11

ATC

mirtazapine; oral

1.3

6.8

586

4798

D10

ICPC

Vomiting

1.7

6.8

126

770

D69.5

ICD-10 Finland

Secondary thrombocytopenia

40.2

6.8

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.6

6.8

K76.9

ICD-10 Finland

Liver disease, unspecified

3.1

6.7

2BD01, ,

NOMESCO Finland

16.7

6.7

PD4ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower extremity arteries

16.7

6.7

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.9

6.7

I50

ICD-10 Finland

Heart failure

2.6

6.7

144

L03

ICPC

Low back symptom/complaint

1.3

6.7

490

3916

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.4

6.7

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

6.7

344

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

22.6

6.7

D11

ICPC

Diarrhoea

1.5

6.7

227

1594

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.7

285

2090

A29

ICPC

General symptom/complaint other

1.5

6.6

196

1336

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.4

6.6

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.6

6.6

145

A05AA02

ATC

ursodeoxycholic acid; oral

2.5

6.6

163

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

2.0

6.6

339

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

12.3

6.6

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

4.2

6.5

R21

ICPC

Throat symptom/complaint

1.3

6.5

424

3328

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.8

6.5

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

6.5

198

1358

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.1

6.5

293

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.8

6.5

557

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

6.5

112

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.9

6.5

101

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.5

224

1578

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

6.4

215

R5599

NOMESCO Finland

Other rehabilitation service

2.2

6.4

241

A10AC01

ATC

insulin (human); parenteral

1.7

6.4

123

758

N80.0

ICD-10 Finland

Endometriosis of uterus

2.3

6.4

197

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.8

6.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

6.4

187

1274

C09CA06

ATC

candesartan; oral

1.4

6.4

375

2900

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.0

6.4

323

J01FA15

ATC

telithromycin; oral

1.5

6.3

173

1160

XLA10, ,

NOMESCO Finland

1.8

6.3

495

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

6.3

133

839

Z01.2

ICD-10 Finland

Dental examination

1.3

6.3

853

7378

A03

ICPC

Fever

1.4

6.3

324

2451

I50.1

ICD-10 Finland

Left ventricular failure

2.1

6.3

277

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

18.1

6.3

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

6.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.9

6.3

K07

ICPC

Swollen ankles/oedema

2.0

6.3

332

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

6.3

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

+∞

6.3

B02BD02

ATC

coagulation factor VIII; parenteral

+∞

6.3

O22.8

ICD-10 Finland

Other venous complications in pregnancy

26.8

6.2

U13

ICPC

Bladder symptom/complaint other

2.2

6.2

238

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.7

6.2

107

641

R01AD05

ATC

budesonide; nasal

1.6

6.2

137

875

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.1

6.2

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

6.2

558

N18

ICPC

Paralysis/weakness

2.7

6.2

115

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.6

6.2

146

948

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

2.8

6.2

104

R03BA01

ATC

beclometasone; inhalant

1.5

6.1

226

1611

TGC00

NOMESCO Finland

Bronchial lavation

2.4

6.1

169

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.1

129

815

Angiography of the heart and coronary arteries

2.0

6.1

342

R96

ICPC

Asthma

1.6

6.1

153

1007

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

6.1

287

A10AB05

ATC

insulin aspart; parenteral

1.7

6.1

119

737

Z49.2

ICD-10 Finland

Other dialysis

4.1

6.1

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.1

146

951

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.5

6.1

184

1262

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

6.1

170

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

6.1

329

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

8.6

6.1

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

6.1

128

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.6

6.1

128

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.6

6.0

134

A02BC03

ATC

lansoprazole; oral

1.3

6.0

445

3555

WZC30

NOMESCO Finland

Teaching

1.4

6.0

243

1762

ZX114

NOMESCO Finland

Intramuscular

2.7

6.0

111

N06AX21

ATC

duloxetine; oral

1.5

6.0

210

1482

SXC03

NOMESCO Finland

Other oral or dental procedure

3.3

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3036489) Thrombin time

623

609

14.31

307.65

4.3

2.3

21.62

21.00

0.98

533

520

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

369

275

16.18

307.65

1.9

1.2

10.23

3.37

u/ml

6.20

201

110

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

342

270

15.03

307.65

1.2

1.1

113.24

117.91

1.14

316

246

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

495

458

13.97

307.65

5.4

2.9

3.40

3.61

g/l

1.72

474

432

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

353

283

14.89

307.65

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

594

519

15.76

307.65

4.5

2.5

97.81

92.31

5.06

570

499

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

384

278

16.80

307.65

1.9

1.2

12.74

3.25

u/ml

4.68

175

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

589

468

17.32

307.65

5.6

2.6

161.99

176.61

2.52

561

445

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

289

187

17.85

307.65

3.4

2.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

267

198

15.37

291.80

1.2

1.1

88.17

95.21

2.22

251

187

(3033658) Prothrombin time (PT) actual/Normal

1099

3946

4.89

277.08

7.4

3.7

84.64

93.59

15.10

1069

3832

(3018677) aPTT in Platelet poor plasma by Coagulation assay

779

2196

5.13

264.62

5.9

2.1

33.34

29.53

20.84

761

2117

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1049

3800

4.64

257.20

3.9

1.7

1.32

0.98

mg/l

2.46

806

2838

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

306

405

8.72

223.04

6.4

3.2

0.35

u/ml

0.02

187

219

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

162

106

16.52

188.18

1.5

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1307

6510

3.83

185.14

43.1

11.8

1.60

1.18

inr

29.39

408

2016

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

63.19

142.57

1.6

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

637

2320

3.54

139.95

5.0

3.4

0.82

mmol/l

0.59

611

2184

(3034426) Prothrombin time (PT)

107

20.48

139.10

1.6

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

474

1479

3.88

130.61

4.4

4.0

233.31

245.04

u/l

0.72

461

1403

(3022096) Basophils/100 leukocytes in Blood

1306

7631

2.99

120.59

9.2

5.9

0.66

0.67

0.50

1250

7142

(3006504) Eosinophils/100 leukocytes in Blood

1328

7903

2.97

117.13

9.2

5.8

2.80

2.84

0.24

1274

7416

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

545

1992

3.37

116.55

4.1

2.4

23.49

23.41

0.04

511

1705

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

253

529

5.32

116.04

3.3

1.8

0.21

0.23

g/l

2.60

244

502

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

126

10.77

115.52

1.6

1.1

1.17

1.05

ratio

2.48

(3019069) Monocytes/100 leukocytes in Blood

1328

7959

2.93

114.52

9.5

6.1

8.51

8.25

2.64

1274

7489

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

256

551

5.17

113.51

3.3

1.8

1.13

1.18

g/l

1.23

247

523

(3004789) Transferrin [Mass/volume] in Serum or Plasma

565

2160

3.24

111.65

3.9

2.3

2.33

2.39

g/l

1.85

540

2016

(3006315) Basophils [#/volume] in Blood

1371

8434

2.93

111.09

9.0

5.8

0.04

e9/l

0.36

1175

7387

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

18.06

110.69

1.3

1.1

86.66

93.86

0.54

(3001604) Monocytes [#/volume] in Blood

1365

8421

2.89

109.18

9.0

5.7

0.57

0.56

e9/l

0.61

1172

7381

(3002030) Lymphocytes/100 leukocytes in Blood

1339

8230

2.84

106.91

9.3

5.8

27.89

28.68

1.94

1284

7768

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

17.19

106.85

1.2

1.1

88.80

92.00

0.34

(3013115) Eosinophils [#/volume] in Blood

1388

8727

2.87

105.38

9.3

6.0

0.19

e9/l

0.19

1219

7785

(3018010) Neutrophils/100 leukocytes in Blood

1323

8118

2.81

105.31

9.1

5.7

57.51

56.81

1.41

1272

7650

(3019198) Lymphocytes [#/volume] in Blood

1383

8707

2.84

104.22

9.0

5.8

1.88

1.95

e9/l

1.07

1216

7822

(3022948) Iron [Moles/volume] in Serum or Plasma

584

2373

3.05

102.85

4.0

2.3

13.42

13.71

umol/l

0.47

569

2213

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

23.77

95.80

1.3

1.2

78.26

64.75

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1109

6438

2.59

95.23

6.5

4.7

35.96

36.14

g/l

0.52

1056

6023

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

10.49

92.65

1.6

1.1

46.56

8.78

u/ml

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1268

7912

2.60

92.48

9.6

6.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

22.71

90.00

1.4

1.1

92.96

85.62

—

(3018418) pH of Serum or Plasma

837

4382

2.55

87.50

5.8

3.7

7.40

0.12

153

832

(3037522) Nuclear Ab [Titer] in Serum

568

2459

2.82

87.19

1.7

1.3

603.86

523.37

titre

0.44

145

498

(3013650) Neutrophils [#/volume] in Blood by Automated count

1434

9669

2.64

86.02

11.8

8.6

3.98

4.04

e9/l

0.37

1243

8500

(3030467) Casts [#/volume] in Urine by Automated count

816

4263

2.53

85.19

4.5

2.9

0.44

0.40

e6/l

0.13

626

3206

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

602

2736

2.71

83.59

4.2

3.4

372.86

422.57

ng/l

0.11

432

1852

(3021589) Normoblasts [#/volume] in Blood

1197

7507

2.45

82.59

13.4

8.5

0.00

e9/l

0.54

948

6168

(3002582) Erythrocytes [#/volume] in Urine

857

4647

2.46

81.72

4.7

3.0

40.77

81.24

e6/l

1.23

668

3539

(36304419) Bacteria [Presence] in Urine

796

4208

2.47

79.87

4.5

2.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

578

2659

2.64

77.52

3.4

2.8

2.43

2.44

mmol/l

0.30

519

2329

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

10.52

77.14

1.1

1.0

89.13

93.30

0.49

(40758558) Short blood count panel - Blood

785

4185

2.43

76.62

8.3

6.4

—

(3018095) Leukocytes [#/volume] in Urine

963

5638

2.35

75.57

5.6

3.5

50.88

89.09

e6/l

1.34

694

3845

(3009445) Proteinase 3 Ab [Units/volume] in Serum

231

629

4.02

75.09

1.7

1.5

6.72

9.70

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

11.73

74.49

1.5

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

198

489

4.38

73.32

1.5

1.6

97.50

141.11

titre

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1078

6717

2.29

71.79

9.5

5.7

1.21

mmol/l

0.36

1026

6165

(3023420) DNA double strand Ab [Units/volume] in Serum

116

181

6.74

71.58

2.5

1.6

38.18

26.67

iu/ml

0.70

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1152

7445

2.26

69.34

9.9

6.3

1.21

mmol/l

0.39

1010

6364

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1217

8066

2.27

68.57

7.2

5.8

11.57

10.82

umol/l

1.05

1162

7639

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1636

12340

2.68

68.22

10.9

7.0

76.74

76.27

u/l

0.16

1574

11644

(3026782) Osmolality of Urine

609

3037

2.44

67.44

3.7

2.7

537.26

537.56

mosm/kgh2o

0.01

525

2614

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

512

2400

2.52

64.51

4.0

2.7

2.95

3.04

e6/l

0.07

257

1275

(3015377) Calcium [Moles/volume] in Serum or Plasma

872

5162

2.21

63.55

3.9

3.2

2.34

2.35

mmol/l

0.43

805

4611

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

731

4033

2.27

63.33

3.3

2.1

2.98

2.86

mg/l

0.53

638

3463

(3027945) Reticulocytes/100 erythrocytes in Blood

369

1485

2.81

63.12

4.1

2.7

1.91

1.76

0.94

332

1339

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

135

7.01

58.79

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

136

6.96

58.39

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

135

6.93

57.54

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

135

6.93

57.54

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

136

6.88

57.15

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

136

6.88

57.15

1.3

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

193

562

3.69

56.56

2.9

1.8

1.35

1.53

g/l

1.82

171

499

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

408

1819

2.56

56.40

3.4

2.8

7.09

7.11

umol/l

0.01

356

1567

(3000850) Epithelial cells [#/volume] in Urine

604

3224

2.24

55.37

3.6

2.5

5.40

6.85

e6/l

1.98

552

2889

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

514

2577

2.33

54.62

3.7

2.5

0.70

1.20

e6/l

1.78

262

1443

(3013826) Glucose [Moles/volume] in Serum or Plasma

1284

9149

2.10

54.33

7.0

4.5

6.34

6.55

mmol/l

3.23

1220

8440

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

167

458

3.88

53.32

1.4

1.2

7.02

2.54

u/ml

1.08

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

883

5530

2.06

52.84

3.9

3.2

30.58

30.40

u/l

0.06

846

5271

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

348

1482

2.63

52.60

3.2

2.4

29.56

70.37

u/l

0.68

300

1254

(3023368) Bacteria identified in Blood by Culture

663

3760

2.13

51.51

6.4

4.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

173

507

3.64

50.10

1.4

1.2

71.98

36.32

u/ml

0.67

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1175

8252

2.01

49.88

4.4

2.8

107.60

97.11

ug/l

0.61

1127

7717

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

164

466

3.74

49.70

1.4

1.3

18.09

6.63

u/ml

0.86

(3044640) Blood type and Crossmatch panel - Blood

827

5142

2.03

49.68

3.3

2.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

296

1194

2.73

49.67

9.5

7.6

9.21

8.70

mmol/l

0.66

280

1140

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

147

389

4.00

49.29

2.6

2.5

0.20

0.02

g/l

0.45

136

361

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

141

362

4.11

49.27

2.4

2.5

0.00

g/l

-0.00

130

337

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

141

365

4.08

48.72

2.4

2.5

0.01

0.00

g/l

0.50

130

338

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

733

4419

2.03

47.51

2.7

2.1

181.47

205.80

u/l

0.34

711

4196

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

155

439

3.74

47.16

2.6

0.51

1.13

g/l

1.58

139

391

(3020630) Protein [Mass/volume] in Serum or Plasma

273

1086

2.75

46.94

2.7

66.19

67.00

g/l

0.97

259

1001

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

183

580

3.37

46.90

3.0

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

136

354

4.05

46.61

1.3

1.2

1.99

4.71

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

629

3608

2.08

46.57

3.2

2.8

1205.85

1075.60

ng/l

0.37

534

3002

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

401

3.85

46.42

2.4

36.94

37.98

g/l

1.25

132

357

(3000991) Gas panel - Venous blood

290

1200

2.65

46.09

13.7

8.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

300

1263

2.61

46.04

3.2

2.7

10.77

10.55

g/l

0.35

286

1160

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

399

3.78

44.43

1.4

1.2

51.00

40.37

u/ml

0.33

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

342

1567

2.42

43.70

2.0

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.91

43.61

1.7

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.81

43.60

1.5

1.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1549

12279

2.10

43.59

6.0

3.9

12.37

10.81

mm/h

4.03

1484

11441

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

483

3.49

43.50

2.5

3.16

2.95

g/l

1.71

144

439

(3026493) Urate [Moles/volume] in Serum or Plasma

667

3992

2.00

43.30

3.4

2.5

2599.36

4922.47

umol/l

1.10

594

3549

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

470

3.51

43.22

2.3

2.5

10.38

10.39

g/l

0.00

141

425

(3031040) Bacteria [#/volume] in Urine by Automated count

1426

10998

2.00

43.00

5.5

4.1

279.84

2179.09

e6/l

1.66

127

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

163

507

3.41

42.97

2.5

7.19

7.32

g/l

0.41

148

463

(3003458) Phosphate [Moles/volume] in Serum or Plasma

383

1860

2.31

42.77

9.1

5.8

1.03

1.05

mmol/l

0.46

360

1730

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

506

3.39

42.41

2.5

3.67

3.57

g/l

0.49

148

463

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

507

3.39

42.28

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

147

435

3.56

41.84

3.5

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1472

11545

2.00

41.39

5.7

4.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

228

883

2.78

41.06

2.4

2.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

246

993

2.68

40.86

2.2

1.8

1.38

1.51

g/l

0.32

234

919

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

338

1587

2.36

40.67

2.0

1.7

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

10.96

40.05

1.7

1.1

88.05

95.45

0.60

(3002385) Erythrocyte distribution width [Ratio]

1780

15080

2.46

39.91

29.9

14.4

14.41

14.58

0.83

1770

14820

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

437

2313

2.13

39.12

2.0

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

110

292

3.93

36.63

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

110

292

3.93

36.63

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

973

6857

1.80

36.31

3.0

2.2

76.69

75.53

nmol/l

0.65

912

6274

(3014111) Lactate [Moles/volume] in Serum or Plasma

275

1250

2.39

35.33

11.7

7.0

1.18

1.34

mmol/l

2.30

265

1211

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

882

6075

1.80

35.22

2.3

1.9

95.66

96.53

pmol/l

0.20

505

3216

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1074

7856

1.78

34.76

3.3

2.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

595

3664

1.88

33.95

1.8

1.4

2.30

2.26

g/l

0.17

379

2311

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

248

1096

2.44

33.86

5.1

3.8

102.69

80.61

ng/l

1.95

224

980

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

622

3891

1.86

33.74

3.2

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

286

1362

2.28

32.87

2.7

2.3

0.22

g/l

0.15

268

1278

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

182

702

2.75

32.84

12.6

10.0

24.05

24.31

mmol/l

0.51

177

683

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

265

1224

2.34

32.71

2.8

2.5

78.92

70.86

ml/min/173m2

3.70

179

462

(3042936) Bacteria identified in Isolate by Culture

398

2163

2.04

32.61

2.3

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

197

795

2.64

32.51

1.7

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

233

1019

2.45

32.50

3.0

2.9

224.81

169.58

ng/l

0.81

207

923

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

164

604

2.87

32.27

1.4

1.3

—

(3044889) 12 lead EKG panel

1383

11033

1.79

31.85

4.2

3.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1804

15765

2.29

30.97

21.7

10.7

86.61

86.74

ml/min/173m2

0.09

1575

12934

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1900

17013

2.81

30.55

23.3

12.1

22.72

21.67

mg/l

0.69

1645

13239

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

134

456

3.08

30.34

4.0

2.1

225.77

431.71

ug/l

0.99

127

425

(3019550) Sodium [Moles/volume] in Serum or Plasma

1893

16950

2.72

29.86

24.6

13.2

139.44

139.61

mmol/l

2.63

1880

16497

(3023103) Potassium [Moles/volume] in Serum or Plasma

1896

17008

2.73

29.45

25.1

13.2

3.92

3.94

mmol/l

1.67

1880

16524

(3023520) Reticulocytes [#/volume] in Blood

233

1074

2.32

28.75

4.2

2.6

78.89

71.15

e9/l

1.41

134

815

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

107

342

3.25

26.90

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

115

386

3.10

26.64

2.9

3.6

8.38

1.70

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

116

394

3.06

26.33

3.1

3.7

30.12

40.14

mg/l

0.66

328

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

101

319

3.28

25.89

1.4

124.50

107.96

u/ml

0.25

(3034860) Kappa light chains.free [Mass/volume] in Serum

115

394

3.03

25.72

3.2

3.7

44.43

73.14

mg/l

0.81

328

(3021879) Hepatitis B virus core Ab [Presence] in Serum

282

1468

2.07

25.54

1.5

1.4

—

(3002032) Base excess in Venous blood by calculation

260

1317

2.12

25.30

7.2

3.9

1.46

1.94

mmol/l

1.39

227

1083

(3017143) Hepatitis C virus Ab [Presence] in Serum

390

2280

1.88

25.20

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

169

717

2.48

25.01

12.1

11.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

766

5456

1.65

24.50

3.7

3.2

41.83

41.09

ng/l

0.02

435

3270

(3021960) Folate [Moles/volume] in Serum or Plasma

528

3409

1.74

24.42

1.8

1.5

18.87

20.70

nmol/l

2.58

469

2948

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

125

4.66

24.35

1.3

1.1

120.00

261.36

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.96

24.22

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

536

3485

1.73

24.13

1.8

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

625

4237

1.69

24.12

2.0

1.9

—

(3003396) Base excess in Arterial blood by calculation

284

1523

2.01

23.60

10.3

8.1

0.28

1.11

mmol/l

2.53

236

1197

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.71

23.42

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

256

1326

2.06

23.40

7.3

3.8

5.90

5.84

kpa

0.47

244

1285

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

110

4.83

23.20

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

284

1533

1.99

23.14

10.5

8.0

12.63

12.78

kpa

0.16

273

1465

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

284

1533

1.99

23.14

10.5

8.1

4.99

5.12

kpa

1.52

273

1461

(3007853) Bacteria identified in Skin by Aerobe culture

332

1901

1.89

22.69

2.3

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

108

387

2.89

22.30

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

213

1056

2.14

21.81

1.8

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

17.27

21.80

1.6

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

195

3.68

21.78

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

613

4231

1.64

21.61

1.7

1.6

1.40

1.37

mmol/l

0.31

536

3629

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

251

3.32

21.43

1.8

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

213

3.52

21.21

2.5

—

(3016502) Oxygen saturation in Arterial blood

252

1348

1.99

20.98

11.3

8.7

95.89

95.90

0.01

245

1302

(3019174) dRVVT (LA screen)

14.76

19.40

1.6

1.1

—

(3015736) pH of Urine

876

6699

1.54

19.39

3.4

3.1

6.15

5.91

1.27

605

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

207

3.42

19.23

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

268

1510

1.89

19.06

4.4

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1926

17900

2.47

18.91

25.0

13.5

77.02

72.76

umol/l

4.15

1926

17894

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

331

2.86

18.88

4.0

3.7

57.97

57.17

0.22

331

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1757

15838

1.81

18.37

5.7

4.8

1.81

1.90

mu/l

0.66

1679

14782

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

303

2.92

18.33

7.5

5.7

344.57

267.03

iu/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

1036

8295

1.51

18.00

4.1

3.4

0.00

estimate

0.99

251

1663

(3026008) Bacteria identified in Urine by Culture

651

4732

1.55

17.74

3.4

2.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

444

2.54

17.56

1.8

2.2

11.82

11.13

mg/l

0.35

100

412

(3024928) Oxygen saturation in Venous blood

305

2.86

17.54

7.6

3.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

300

2.88

17.48

3.0

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1041

8379

1.50

17.39

4.2

3.4

0.00

0.01

estimate

1.06

233

1546

(3000494) Fungus identified in Specimen by Culture

314

1912

1.76

17.23

1.8

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1032

8302

1.49

17.22

6.0

4.6

0.00

estimate

0.50

243

1591

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1375

11739

1.53

17.16

3.4

3.0

46.82

41.68

u/l

1.50

1309

11110

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1927

18007

2.37

17.03

15.3

9.3

27.34

25.66

u/l

2.47

1893

17445

(3024980) IgG subclass 4 [Mass/volume] in Serum

274

2.92

16.73

1.8

1.6

0.73

0.75

g/l

0.06

205

(40768804) Tissue Pathology biopsy report

871

6808

1.49

16.53

2.2

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

460

3133

1.61

16.41

1.4

1.3

24.23

28.92

iu/ml

0.58

130

1006

(3029075) Extractable nuclear Ab panel - Serum

5.73

16.34

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

535

3780

1.56

16.29

3.6

3.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

205

1113

1.94

16.22

6.2

3.3

4.85

4.69

kpa

0.42

192

1073

(3007566) Smooth muscle Ab [Titer] in Serum

108

455

2.45

16.21

1.3

1.2

98.00

85.79

titre

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

148

716

2.15

16.07

1.9

2.1

38.88

39.34

u/l

0.09

129

645

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.23

15.81

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.23

15.81

1.8

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

352

2.63

15.77

1.3

282.45

258.79

u/ml

0.18

214

(3051611) Lipemic interference index of Serum or Plasma

140

3.64

15.50

4.3

3.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

274

1652

1.76

15.47

2.4

2.1

345.09

374.38

nmol/l

1.71

263

1525

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

293

2.76

15.35

1.6

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

100

417

2.47

15.35

1.8

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

283

2.79

15.23

3.0

2.4

17.77

16.66

1.60

143

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

372

2.54

15.08

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

213

1199

1.87

15.07

4.8

4.2

0.07

0.38

0.57

286

(3002179) Metamyelocytes/100 leukocytes in Blood

215

1215

1.86

15.03

4.5

3.8

0.72

0.68

0.09

361

(3024891) Influenza virus A+B Ag [Presence] in Specimen

113

503

2.32

15.01

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1529

13552

1.52

14.30

4.7

4.1

14.52

14.55

pmol/l

0.15

1441

12546

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

626

2.15

14.28

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

154

3.37

14.13

1.7

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

579

4277

1.49

13.98

1.4

1.3

0.75

1.55

u/ml

3.47

131

1167

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1641

14795

1.57

13.94

5.7

5.0

38.59

38.83

mmol/mol

0.51

1554

13869

(3002256) Pathology report gross observation

319

2060

1.65

13.91

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

217

1263

1.80

13.76

4.9

4.1

0.13

0.11

0.06

348

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

649

4932

1.46

13.49

3.0

2.5

54.89

74.07

u/l

0.63

613

4581

(3051651) Icteric interference index of Serum or Plasma

4.03

13.37

4.7

3.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

9.74

13.21

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

203

2.96

13.19

1.4

1.5

—

(3042733) HLA Ab [Presence] in Serum

5.49

13.07

4.3

5.0

—

(3012501) Base excess in Blood by calculation

314

2.54

12.93

5.7

3.8

1.99

2.34

mmol/l

0.54

204

(40768797) Stomach Pathology biopsy report

332

2207

1.60

12.81

1.3

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

222

1331

1.75

12.70

4.9

4.0

0.91

0.98

0.16

416

(3040151) Glucose [Moles/volume] in Capillary blood

145

3.29

12.62

11.4

7.3

6.91

6.92

mmol/l

0.01

118

(3019309) Folate [Moles/volume] in Red Blood Cells

367

2512

1.56

12.47

2.0

1.7

1016.05

1180.39

nmol/l

3.31

298

1926

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

4.40

12.17

1.4

13.33

14.34

u/l

0.25

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.96

12.16

1.8

3.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

18.15

12.04

1.3

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

417

2963

1.51

11.88

1.3

9.47

11.05

u/ml

0.19

119

1228

(3037756) Immunofixation for Serum or Plasma

276

2.55

11.62

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

408

2.26

11.51

2.5

2.8

—

(3000492) Spirometry study

270

1751

1.63

11.47

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1427

12690

1.42

11.30

4.0

3.4

—

(1002224) Polysomnography panel

143

778

1.90

11.22

1.1

—

(40761511) CBC panel - Blood by Automated count

1895

17915

1.86

11.20

19.4

11.4

—

(3022145) Colonoscopy Study observation

271

1779

1.60

10.93

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

337

2330

1.54

10.83

2.3

2.4

130.50

111.22

ug/g

0.45

269

1847

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

376

2.26

10.65

1.1

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

120

3.29

10.55

1.2

69.40

42.67

u/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

196

1196

1.71

10.50

2.2

2.4

22.07

24.15

au/ml

—

108

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

121

3.27

10.42

1.2

47.50

61.45

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

194

1187

1.70

10.29

3.2

3.4

4.36

4.55

pmol/l

2.07

172

1063

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

112

3.35

10.28

1.2

3.20

2.40

u/ml

—

(3024471) HLA-A [Type]

4.74

10.24

1.0

—

(3003338) MCHC [Mass/volume]

1640

15056

1.46

10.14

29.9

15.3

331.20

332.63

g/l

8.23

1635

14946

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

2.49

10.14

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

589

4592

1.40

10.04

4.1

3.2

7.32

7.80

mmol/l

1.72

517

3965

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.69

9.98

1.7

2.8

549.81

1073.52

u/ml

1.61

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1791

16760

1.58

9.96

5.3

4.3

2.66

2.83

mmol/l

13.23

1690

15688

(3003327) Ova and parasites identified in Stool by Light microscopy

118

630

1.93

9.82

2.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

121

3.18

9.75

3.2

3.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

3.28

9.73

2.4

—

(3045142) Bone marrow Pathology biopsy report

149

2.93

9.57

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1768

16527

1.54

9.54

4.7

4.0

4.51

4.73

mmol/l

17.25

1675

15571

(3024932) HLA-DR beta [Type]

4.62

9.53

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

330

2.26

9.45

2.9

2.4

5.14

4.92

umol/l

0.15

243

(3012516) Albumin [Mass/volume] in Urine

522

4030

1.40

9.31

4.1

3.3

453.33

376.04

mg/l

0.13

362

2599

(3010375) cycloSPORINE [Mass/volume] in Blood

3.84

9.23

23.0

27.2

109.00

116.37

ug/l

0.20

(3006184) Hemoglobin [Mass/volume] in Capillary blood

308

2.28

9.20

2.6

2.3

132.87

132.45

g/l

0.04

232

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

100

3.34

9.18

1.2

1.5

5.06

6.43

u/l

0.83

(40761536) Microorganisms panel - Urine sediment

225

1472

1.59

9.16

5.2

3.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

259

2.40

9.12

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

102

3.27

8.90

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

202

2.56

8.83

1.5

—

(3011648) Oxygen content in Venous blood

113

3.13

8.81

2.7

3.4

9.57

11.16

1.14

113

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1755

16443

1.50

8.69

4.7

3.9

1.41

1.48

mmol/l

11.11

1647

15406

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

104

555

1.92

8.69

1.4

1.5

0.04

0.18

iu/ml

0.73

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

188

1194

1.63

8.64

4.8

3.2

1.22

1.23

mmol/l

0.78

174

1030

(3000093) Morphology [Interpretation] in Blood Narrative

115

3.08

8.56

1.2

1.1

—

(1616796) Gas panel - Central venous blood

305

2.24

8.56

5.2

3.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1698

15827

1.44

8.45

4.2

3.6

1.30

1.26

mmol/l

0.85

1587

14755

(3020682) Albumin/Creatinine [Ratio] in Urine

539

4247

1.37

8.35

5.0

3.8

11.59

9.32

mg/mmol

0.59

363

2720

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

103

3.14

8.11

1.1

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

17.24

8.07

1.3

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

126

2.89

7.92

1.6

1.4

33.02

32.73

g/l

0.04

110

(3021788) Differential panel - Synovial fluid

258

2.28

7.85

1.3

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

190

1240

1.59

7.81

1.5

1.3

129.36

218.11

u/ml

1.71

182

1146

(3045788) Cell count panel - Pleural fluid

3.25

7.80

1.7

1.3

—

(3003694) ABO and Rh group [Type] in Blood

630

5126

1.33

7.80

1.7

1.6

—

(3021901) Oxygen saturation in Capillary blood

240

2.33

7.78

3.3

2.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

173

2.58

7.77

1.5

1.4

2.48

2.85

g/l

0.91

117

(3024139) IgG subclass 3 [Mass/volume] in Serum

173

2.58

7.77

1.5

1.4

0.27

0.39

g/l

2.82

115

(3027135) IgG subclass 1 [Mass/volume] in Serum

173

2.58

7.77

1.5

1.4

7.29

6.88

g/l

0.24

117

(3014765) Yersinia sp identified in Stool by Organism specific culture

519

1.89

7.75

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

292

2.19

7.73

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

166

1054

1.63

7.65

1.8

2.3

10.48

6.73

ug/l

0.89

145

936

(3004616) Nuclear Ab [Presence] in Serum

193

2.47

7.60

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

102

3.07

7.59

1.6

1.3

—

(36660697) Celiac disease serology panel - Serum

219

1486

1.53

7.58

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

518

1.87

7.48

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

159

2.61

7.46

2.7

2.0

31.56

32.08

0.25

159

(42529406) Shigella sp [Presence] in Stool by Culture

526

1.87

7.45

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

109

2.97

7.40

1.1

1.0

—

(4062490) Immunoglobulin typing, IgG

178

2.50

7.35

1.6

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

126

2.81

7.34

1.7

1.5

—

(40768443) Skin Pathology biopsy report

112

647

1.77

7.32

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

209

2.38

7.31

1.5

1.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

10.89

7.29

1.3

1.8

4.92

0.40

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

10.89

7.29

1.3

1.8

0.69

0.75

mg/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.18

7.27

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

180

2.48

7.19

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

111

2.91

7.17

1.6

1.3

1211.33

2069.11

e6/l

1.29

(21494434) Karyotype in Bone marrow

111

2.91

7.17

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.36

7.11

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

290

2.14

7.06

1.0

1.1

—

(4200892) Spirometry reversibility

170

1108

1.58

7.04

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

298

2.11

6.98

4.5

3.0

36.21

34.04

umol/l

0.40

272

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

102

2.97

6.97

1.5

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

374

1.99

6.93

1.7

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1701

15989

1.39

6.92

4.7

4.0

5.76

5.80

mmol/l

0.52

1585

14779

(3023419) Bacteria identified in Sputum by Culture

202

2.36

6.91

3.1

2.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.55

6.90

1.9

1.8

—

(3000012) Reticulocyte production index

166

2.50

6.86

3.5

2.0

—

(3045414) Leukocytes [Presence] in Urine

123

744

1.70

6.85

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

1970

19125

2.00

6.82

35.2

17.9

39.75

40.19

2.87

1919

18095

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.99

6.81

1.7

1.3

233073.05

38944.00

e6/l

0.40

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

129

792

1.67

6.80

2.0

1.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.32

6.69

1.1

167.72

177.60

iu/ml

0.08

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

2.62

6.63

4.3

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

140

885

1.63

6.59

1.7

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

555

1.79

6.58

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

170

1128

1.55

6.52

2.8

2.2

3239.62

5385.10

u/l

0.81

447

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

369

1.96

6.49

1.7

1.6

—

(3007461) Platelets [#/volume] in Blood

1970

19145

1.97

6.48

34.4

17.8

250.78

258.68

e9/l

5.46

1944

18712

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

499

4016

1.32

6.48

1.7

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

124

2.69

6.42

2.4

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

501

1.81

6.38

3.2

3.4

79.12

2861.22

u/ml

0.79

431

(3011412) CD3 cells [#/volume] in Blood

149

2.51

6.28

2.4

2.7

1.12

1.30

e9/l

0.54

140

(3010813) Leukocytes [#/volume] in Blood

1970

19157

1.94

6.28

34.4

17.8

6.81

6.74

e9/l

0.58

1939

18677

(3024731) MCV [Entitic volume]

1970

19157

1.94

6.28

34.3

17.8

90.57

90.49

0.34

1964

18925

(3035941) MCH [Entitic mass]

1970

19158

1.94

6.26

34.3

17.7

30.06

30.16

1.83

1964

18923

(3026361) Erythrocytes [#/volume] in Blood

1970

19160

1.94

6.23

34.4

17.8

4.47

4.51

e12/l

3.38

1941

18692

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

150

2.49

6.20

1.1

201.19

230.31

mg/l

0.69

128

(21494890) Protein electrophoresis panel - 24 hour Urine

139

2.54

6.12

2.1

2.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

116

2.70

6.09

1.1

1.00

1.07

u/l

0.62

(3000963) Hemoglobin [Mass/volume] in Blood

1970

19169

1.92

6.08

34.7

17.9

133.01

135.32

g/l

11.12

1965

18928

(3019832) Treponema pallidum Ab [Presence] in Serum

336

2582

1.36

5.91

1.7

—

(3008898) HLA-B27 [Presence]

120

751

1.64

5.90

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

102

2.77

5.80

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

200

2.23

5.74

1.1

1.3

—

(3025941) Bacteria identified in Stool by Culture

157

1054

1.53

5.73

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

138

2.49

5.71

1.4

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

6.12

5.69

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

238

2.09

5.44

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

131

856

1.57

5.41

1.4

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

423

1.80

5.39

2.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.63

5.37

5.2

6.4

—

(3044290) Cell count panel - Cerebral spinal fluid

358

1.87

5.37

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.89

5.34

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

145

974

1.53

5.30

1.6

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

11.29

5.29

1.0

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

531

1.71

5.28

1.3

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

101

624

1.65

5.26

1.3

1.4

10.56

10.05

u/l

0.13

507

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

135

897

1.54

5.19

6.0

3.8

1.32

1.68

mmol/l

0.60

669

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.35

5.08

13.7

7.5

6.64

6.92

mmol/l

0.05

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

204

1479

1.42

5.07

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

2.48

5.05

1.5

33.61

34.78

0.05

(3009343) pH of Capillary blood

138

928

1.52

5.03

5.9

3.8

7.42

7.41

0.69

107

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

10.04

5.02

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

120

784

1.56

4.98

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

120

785

1.56

4.95

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

286

2203

1.35

4.93

2.1

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

276

1.94

4.90

3.6

2.7

—

(3044941) Cell count panel - Synovial fluid

221

2.06

4.88

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

292

2261

1.34

4.86

1.7

1.8

1.41

1.43

0.21

260

2020

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.72

4.85

1.1

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

138

937

1.51

4.82

5.9

3.8

5.05

5.16

kpa

1.10

131

899

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

189

2.14

4.80

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

394

1.78

4.80

1.5

309.90

1429.73

e6/l

0.89

324

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

394

1.78

4.80

1.5

19.72

18.31

e6/l

0.04

308

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

196

2.11

4.78

1.1

—

(40768806) Pleura Pathology biopsy report

114

2.48

4.71

1.8

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

152

2.26

4.67

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

376

1.78

4.63

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

118

782

1.54

4.62

1.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.14

4.60

2.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

118

783

1.54

4.59

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

145

1006

1.48

4.57

2.2

10.73

11.86

nmol/l

0.88

128

903

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.24

4.45

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

189

2.08

4.41

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

450

1.69

4.41

1.5

1.4

288.30

302.49

ug/g

0.21

245

(3047189) Immunofixation for 24 hour Urine

3.02

4.40

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.02

4.40

1.1

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

138

2.27

4.32

2.5

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

340

1.79

4.31

1.5

1.8

17040.11

14658.44

e6/l

0.10

251

(3021387) Prolactin [Units/volume] in Serum or Plasma

135

939

1.47

4.22

1.4

1.6

285.86

303.28

mu/l

0.30

121

838

(3000060) B lymphocytes [#/volume] in Blood

3.15

4.21

1.4

2.4

180.00

236.00

e6/l

—

(3009871) Measles virus Ab [Titer] in Serum

3.15

4.21

1.6

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.87

4.19

3.1

2.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.92

4.17

1.2

1.3

4.67

4.82

—

(4035726) Immunohistochemistry procedure

178

1306

1.40

4.16

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

271

1.87

4.15

1.6

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

2.35

4.09

1.6

2.8

527.59

559.64

e6/l

0.10

105

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

185

1373

1.38

4.05

3.3

4.2

4.58

25.12

ug/l

2.09

131

1084

(3049717) Cytology report of Urine Cyto stain

470

1.64

4.01

2.3

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

546

4676

1.23

4.00

4.1

3.0

—

(3035880) pH of Pleural fluid

2.90

3.90

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

2.90

3.90

1.9

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.58

3.88

1.1

—

(3003181) Sodium [Moles/volume] in Urine

228

1.91

3.84

1.6

1.4

75.45

65.98

mmol/l

0.53

191

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

200

1.97

3.83

1.6

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

12.03

3.76

1.2

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

647

1.52

3.74

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

181

2.01

3.74

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.65

3.73

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.39

3.65

1.8

1.5

1.39

6.84

u/l

2.85

(3016018) Differential panel - Cerebral spinal fluid

176

2.01

3.64

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

135

971

1.42

3.57

1.1

—

124.00

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.80

3.56

1.1

4.29

11.56

u/l

—

(3010937) Rubella virus Ab [Presence] in Serum

5.31

3.51

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.02

3.50

1.8

4.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.02

3.50

1.8

4.0

—

(3037121) Protein [Mass/volume] in Urine

544

1.55

3.49

3.9

3.7

0.29

0.27

g/l

0.10

225

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

258

1.80

3.48

1.2

1.1

—

(3022621) pH of Urine by Test strip

146

1070

1.39

3.47

2.8

2.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.90

3.46

2.4

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

168

1261

1.36

3.46

1.3

1.4

24.85

24.77

iu/l

0.01

141

1071

(3042631) Mycobacterium sp identified in Specimen

173

1.98

3.44

2.9

2.6

—

(3005033) Fetal Nuchal fold Thickness US

644

1.50

3.42

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

167

1.99

3.39

1.4

1.6

50.91

56.78

0.32

109

(3045424) Erythrocytes [Presence] in Urine

276

1.76

3.35

1.4

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

314

1.71

3.34

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

666

1.48

3.30

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

188

1448

1.33

3.27

1.3

1.2

199.25

142.82

iu/ml

0.69

558

(3004716) Salmonella sp identified in Stool by Organism specific culture

144

1065

1.38

3.26

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

220

1.83

3.24

1.2

1.1

1.49

g/l

0.01

202

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

317

1.69

3.24

1.1

1.0

0.83

2.08

u/ml

2.62

155

(3026389) Candida sp identified in Specimen by Organism specific culture

221

1.83

3.20

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.87

3.19

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.48

3.13

1.6

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

276

1.72

3.08

1.1

—

(3013512) EKG study

480

4158

1.20

3.05

3.8

3.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.90

3.02

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.90

3.02

4.8

4.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.35

3.01

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

278

1.71

3.01

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

278

1.71

3.01

1.7

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

263

1.73

3.00

1.1

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

113

2.14

3.00

1.7

2.8

0.19

0.20

e9/l

0.19

105

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.55

2.95

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

232

1870

1.27

2.89

1.8

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.70

2.89

2.1

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.70

2.89

3.0

2.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.40

2.87

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.40

2.87

1.4

1.8

170.14

123.62

ug/g

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.68

2.87

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

562

1.48

2.85

1.1

2.28

4.26

u/ml

0.58

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.46

2.69

1.2

1.3

—

(4034850) Laboratory test

533

0.56

2.67

7.5

8.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.34

2.65

1.6

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

102

740

1.40

2.64

2.5

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.66

2.62

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

155

1.88

2.61

1.5

1.1

—

(3025130) Human papilloma virus identified in Specimen

329

1.60

2.61

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

251

2068

1.24

2.61

2.8

0.73

0.72

ug/l

0.08

163

1288

(3050794) Legionella sp Ab [Presence] in Serum

4.68

2.59

1.3

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

346

1.58

2.58

4.4

2.3

0.98

0.83

nmol/l

0.61

292

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

402

1.53

2.58

1.5

1.4

0.66

0.39

nmol/l

0.36

326

(3020393) Adenovirus Ag [Presence] in Stool

3.61

2.57

1.2

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.07

2.56

1.3

1.2

1.00

3.04

0.53

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

114

2.03

2.56

2.7

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.16

2.55

1.4

2.6

—

(3033799) Differential panel - Peritoneal fluid

2.74

2.54

1.8

2.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

5.47

2.54

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

157

1.86

2.52

1.2

4.03

2.27

u/ml

0.28

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

135

1745

0.76

2.52

5.3

6.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.24

2.51

1.3

1.1

—

(3019060) Gas panel - Arterial blood

116

868

1.36

2.50

5.1

5.8

—

(21494755) Public health laboratory ask at order entry panel

168

2095

0.78

2.39

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

410

1.50

2.38

1.2

—

(3000330) Specific gravity of Urine by Test strip

101

746

1.37

2.38

2.9

3.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.26

2.37

1.8

4.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.65

2.36

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

170

1.78

2.29

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.95

2.28

4.5

6.9

—

(40765096) Chromosome analysis panel by Banding

2.95

2.28

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

398

1.50

2.27

1.7

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.76

2.27

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.63

2.27

1.3

16.33

10.17

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

440

1.47

2.25

1.8

1.7

41.80

40.49

nmol/l

0.16

428

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

136

1060

1.30

2.25

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.11

2.22

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

135

1.86

2.22

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

135

1.86

2.22

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.57

2.21

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.57

2.21

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.69

2.20

1.1

1.7

0.18

0.15

nmol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

509

1.43

2.20

1.5

2.0

2.35

4.81

iu/l

5.40

189

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

129

1.87

2.17

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

250

1.61

2.16

1.7

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

354

1.51

2.16

2.2

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

108

1.95

2.15

1.5

2.7

39.86

45.11

—

(3030313) Adrenal Ab [Titer] in Serum

3.69

2.15

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.69

2.15

1.3

3.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.69

2.15

1.1

1.3

—

(40757373) Influenza virus identified in Isolate

3.01

2.14

1.7

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.79

2.13

4.5

6.8

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

198

1.68

2.09

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

198

1.68

2.09

1.6

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

2.07

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.01

2.07

1.8

4.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.51

2.05

1.0

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

132

1.83

2.04

2.4

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.11

2.02

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.23

2.01

1.4

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

178

1.70

1.99

3.5

4.6

237.95

92.53

u/ml

0.30

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

148

1.77

1.98

1.1

1.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

496

1.40

1.96

3.3

2.0

1.02

1.82

ug/l

0.61

442

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

317

2752

1.18

1.95

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.20

1.94

4.5

3.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.55

1.94

1.4

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

4.55

1.94

1.0

1.1

—

29.83

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.84

1.93

1.4

—

(3017704) Immunofixation for Urine

2.06

1.91

1.2

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

680

1.34

1.89

1.9

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.98

1.85

1.6

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

127

1011

1.27

1.83

2.0

2.7

32.74

46.80

u/ml

0.79

121

977

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

238

1.56

1.82

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

616

1.35

1.80

1.3

—

(40768441) Liver Pathology biopsy report

123

1.80

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.58

1.80

1.6

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

3.05

1.80

1.6

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

721

1.32

1.80

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

1.82

1.78

1.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

200

1.61

1.77

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

393

3497

1.15

1.77

4.2

4.6

2.35

2.51

ug/l

0.13

357

3153

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

338

1.46

1.76

1.2

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

486

4395

1.14

1.73

4.6

3.7

0.00

0.01

estimate

1.49

241

1566

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.92

1.72

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

194

1.61

1.72

1.1

1.3

—

nmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

349

3089

1.16

1.69

2.2

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

151

1826

0.81

1.68

4.4

4.1

32.73

31.93

0.38

120

1311

(3008295) Osmolality of Serum or Plasma

164

1.66

1.68

1.6

1.7

289.84

281.35

mosm/kgh2o

1.36

131

(3020876) Protein [Mass/time] in 24 hour Urine

149

1.69

1.67

2.0

2.7

0.65

1.49

g/24h

—

(3044007) Cell count panel - Peritoneal fluid

2.45

1.64

2.0

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

750

1.29

1.63

1.4

1.3

237.77

227.45

miu/ml

0.09

377

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.51

1.59

1.0

1.2

2.73

5.31

nmol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.70

1.58

2.7

2.1

—

(3022313) Gas panel - Capillary blood

694

1.30

1.55

7.2

3.9

—

(3017732) Neutrophils [#/volume] in Blood

146

1208

1.22

1.54

3.0

2.7

4.60

5.33

e9/l

0.60

122

1035

(1761868) Lipid panel - Serum or Plasma

598

6464

0.89

1.53

2.7

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

265

2316

1.17

1.53

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

169

1.61

1.52

1.2

2.4

16.80

20.74

nmol/l

1.52

163

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.60

1.51

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

218

1.52

1.49

2.3

3.2

0.87

0.85

nmol/l

0.10

172

(3044927) Protein electrophoresis panel - Urine

139

1.66

1.48

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.13

1.44

1.8

6.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

303

1.43

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

157

1.60

1.40

2.2

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

689

6431

1.11

1.40

4.2

3.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.61

1.36

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.95

1.36

1.2

1.4

166.00

103.24

ng/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.92

1.33

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

128

1.65

1.33

1.0

1.1

9.80

11.93

iu/ml

—

(3047181) Lactate [Moles/volume] in Blood

445

1.34

1.33

5.2

8.0

1.30

1.23

mmol/l

0.20

392

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

184

1.53

1.32

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.50

1.30

1.3

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.10

1.30

1.1

6.06

0.31

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.78

1.28

1.0

—

(40768795) Lymph node Pathology biopsy report

138

1.60

1.26

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

107

1.69

1.26

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.82

1.25

1.1

1.4

169.57

163.34

mmol/24h

0.09

(37021550) Renin [Units/volume] in Plasma --upright

2.23

1.24

1.0

1.4

33.25

67.80

mu/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

356

1.36

1.22

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.64

1.21

1.2

1.0

0.83

0.38

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.17

1.21

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

101

1.69

1.20

1.7

—

(3001556) Androgen free Index in Serum or Plasma

2.31

1.18

1.2

—

(4281824) Cell count and differential, peritoneal fluid

181

1.50

1.18

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

149

1.55

1.17

1.9

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

2.00

1.16

13.0

9.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

134

1.57

1.14

1.4

1.5

0.92

0.96

g/l

0.30

134

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

134

1.57

1.14

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.79

1.11

1.7

2.8

1.72

1.11

ug/l

0.24

(3003740) Influenza virus B Ag [Presence] in Specimen

355

1.33

1.09

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.73

1.09

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.73

1.09

1.8

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.95

1.08

1.7

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

185

1.47

1.08

1.1

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.87

1.07

1.5

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

339

1.33

1.07

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

130

1.54

1.02

2.4

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

188

1.44

1.01

1.1

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

188

1.44

1.01

1.1

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

147

1.50

1.00

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.65

1.00

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.00

1.00

1.3

1.1

28.87

28.78

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.00

1.00

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.84

0.98

1.7

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.18

0.98

1.2

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.18

0.98

1.0

1.2

1.29

1.77

umol/24h

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

460

1.27

0.97

1.2

1.1

1.48

2.49

u/ml

0.56

240

(3015076) Soybean IgE Ab [Units/volume] in Serum

132

1.52

0.97

1.1

0.10

0.93

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

352

0.71

0.95

2.9

2.3

36.00

111.20

ug/min

2.22

219

(3020874) Milk IgE Ab [Units/volume] in Serum

141

1.49

0.95

1.1

18.91

2.87

u/ml

0.39

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.78

0.94

1.3

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.15

0.91

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

118

1.53

0.91

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

111

1.54

0.87

1.5

2.2

2.20

2.29

u/field

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.88

0.81

2.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.88

0.81

2.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.88

0.81

2.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

241

1.33

0.80

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

131

1150

1.15

0.80

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.82

0.79

1.2

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

411

1.25

0.78

1.1

—

(3024263) Appearance of Synovial fluid

1.63

0.78

1.5

1.6

—

(3036180) Methadone [Presence] in Urine

1.56

0.78

3.1

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

314

1.28

0.76

1.4

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

422

1.24

0.76

1.2

1.1

5.46

5.07

u/ml

0.07

232

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.60

0.75

2.7

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

289

1.29

0.74

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

1463

1.12

0.72

1.7

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

0.72

1.8

1.9

—

(3019150) Specific gravity of Urine by Refractometry

381

3571

1.08

0.71

3.7

1.02

kg/l

0.34

512

(3028433) Virus identified in Specimen by Culture

1.58

0.71

1.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

186

1.35

0.70

1.1

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

152

1.39

0.69

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

300

2789

1.09

0.68

3.7

4.0

23.27

21.25

1.08

110

1239

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

187

1.34

0.68

1.1

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

293

1.27

0.68

1.1

13.20

1738.59

iu/ml

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

188

1.33

0.66

1.1

1.5

—

(3006462) Nitrate [Presence] in Urine

1.57

0.65

2.4

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

180

1.34

0.65

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

347

0.78

0.62

1.7

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

199

1.31

0.62

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

792

0.85

0.62

1.5

—

(3004451) EKG impression Narrative

1.57

0.58

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.58

0.0

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.46

0.58

2.0

1.3

132.15

138.57

nmol/l

0.35

(3048879) Bone marrow aspiration report

1.72

0.57

1.8

2.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

285

1.23

0.54

2.4

3.9

24.46

27.12

u/ml

0.09

278

(3008757) Leukocyte morphology finding [Identifier] in Blood

160

1.32

0.53

3.1

3.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.54

0.53

1.7

1.5

—

(40761535) Cells panel - Urine sediment

108

1201

0.89

0.53

3.2

3.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

161

1.31

0.51

1.7

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.50

0.51

2.0

3.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.50

0.51

4.0

2.3

15.38

16.59

umol/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.50

0.51

2.0

3.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.41

0.51

1.9

1.4

108.33

84.93

nmol/24h

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

144

1.32

0.50

1.1

0.23

1.44

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

1.46

0.50

2.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.49

0.49

1.6

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.49

0.49

1.6

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

102

1.38

0.47

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.47

0.47

1.6

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

403

1.17

0.45

1.2

1.1

0.85

1.09

u/ml

0.18

176

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

103

1.36

0.45

2.7

3.0

40488.00

40107.82

ug/l

0.02

103

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.40

0.45

1.0

1.1

25.36

41.33

u/ml

—

(3020650) Glucose [Presence] in Urine

1.40

0.45

1.1

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

388

3709

1.06

0.44

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

602

1.13

0.43

2.1

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

818

0.89

0.43

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.41

0.42

1.5

2.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

140

1.29

0.42

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

140

1.29

0.42

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

140

1.29

0.42

1.7

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.6

—

7.13

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3014271) Vancomycin [Susceptibility]

1.36

0.41

2.3

2.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.36

0.41

1.1

1.5

10.71

8.81

ug/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.40

0.0

1.3

—

5.60

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

550

1.13

0.39

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.31

0.39

3.5

2.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

115

1.31

0.39

1.4

1.3

1.44

1.57

g/l

1.24

115

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

124

1.29

0.38

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.37

0.38

1.2

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.34

0.38

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.35

0.38

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.31

0.37

2.1

2.2

—

173.93

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

125

1.28

0.37

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

281

1.18

0.36

1.4

6.68

7.10

mmol/l

0.43

251

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.40

0.35

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

115

1240

0.92

0.34

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.37

0.34

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.33

0.33

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.33

1.3

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.31

0.33

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

400

1.13

0.30

1.1

1.09

1.89

u/ml

0.63

200

(3011288) Drugs identified in Urine by Screen method

631

1.10

0.29

4.3

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

108

0.74

0.29

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

1.24

0.28

1.7

1.3

67.00

74.31

umol/l

0.86

121

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

642

1.09

0.28

2.0

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

730

0.92

0.27

1.5

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.23

0.27

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.26

0.26

1.7

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.25

0.25

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

329

3186

1.04

0.25

1.8

1.6

433.24

38645988.99

pmol/l

3.49

273

2717

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

1.24

0.24

7.2

6.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.28

0.23

1.0

1.1

52.84

72.04

ug/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

125

1.20

0.22

8.6

13.2

746.13

853.97

nmol/l

0.38

120

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.19

0.21

1.8

1.5

61.10

48.02

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

2.9

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

55.00

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.04

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

174

1813

0.96

0.21

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

21.02

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

702

1.07

0.21

2.3

2.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.25

0.20

2.6

1.6

—

1028900.00

iu/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.20

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.23

0.20

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.20

0.19

1.3

1.1

—

(3019225) pH of Specimen

137

1432

0.95

0.19

5.4

3.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

133

0.83

0.19

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

133

0.83

0.19

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

146

1.17

0.19

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.15

0.19

3.0

3.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.13

0.18

1.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.13

0.18

1.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

406

1.09

0.18

3.2

2.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

341

0.91

0.17

1.1

1.21

4.53

u/ml

2.17

160

(3017569) Oxygen content in Arterial blood

1.18

0.16

2.0

3.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

321

1.09

0.16

7.0

3.5

16.94

22.21

mg/l

0.91

206

(3035933) Granulocytes/100 leukocytes in Blood

1.13

0.16

1.1

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.20

0.16

1.0

1.2

1825.36

1471.66

miu/ml

0.66

(4146454) Self-monitoring of blood glucose

130

0.85

0.16

5.4

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.10

0.15

2.5

2.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

286

0.91

0.15

1.1

0.06

0.30

u/ml

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

559

1.06

0.13

4.9

6.6

1.72

1.58

0.53

527

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

543

1.05

0.11

1.9

1.8

—

(40768793) Breast Pathology biopsy report

440

0.95

0.08

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.04

0.08

1.1

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.12

0.07

1.0

1.4

215.68

157.22

pmol/l

0.87

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

304

1.05

0.07

2.3

1.8

192.44

196.97

pmol/l

0.06

282

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

790

1.03

0.06

1.5

1.7

3.52

4.13

mg/l

0.26

558

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

124

1261

0.98

0.05

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

299

1.04

0.03

1.8

1.5

—

(3020891) Body temperature

530

1.02

0.02

5.7

4.7

—

(3016879) Cocaine [Presence] in Urine

832

1.01

0.01

2.7

2.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

154

1.04

0.00

3.2

2.4

—

(3027944) Amphetamines [Presence] in Urine

896

0.99

0.00

2.6

2.0

—

(3027008) Opiates [Presence] in Urine

904

1.01

0.00

2.6

2.0

—

(3015183) Erythrocyte sedimentation rate

109

1.01

0.00

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

345

1.01

0.00

3.5

4.1

—

(3000764) Benzodiazepines [Presence] in Urine

899

1.00

0.00

2.6

2.0

—

(40768800) Prostate Pathology biopsy report

204

0.98

0.00

1.2

—

(3028300) Cannabinoids [Presence] in Urine

906

1.00

0.00

2.6

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

308

1.01

0.00

1.1

0.77

5.21

u/ml

4.29

120

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.91

0.00

6.8

6.6

—

57.85

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.86

0.00

1.2

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1479.17

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.95

-0.00

1.6

1.8

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.92

-0.00

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

-0.00

0.0

2.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_COAGDEFNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_COAGDEFNAS	1.772 [1.5, 2.09]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.663

During the follow-up period (1.1.1998 — 31.12.2019), 528 out of 6334 females with D3_COAGDEFNAS died.

Males

Parameter	HR [95% CI]	p-value
D3_COAGDEFNAS	1.758 [1.5, 2.06]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 579 out of 3194 males with D3_COAGDEFNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_COAGDEFNAS.

N-year risk	Females	Males
1	0.219%	0.381%
5	1.244%	2.273%
10	2.897%	5.384%
15	5.705%	10.407%
20	9.837%	17.933%

Relationships between endpoints

↥

Index endpoint: D3_COAGDEFNAS – Other and unspecified coagulation defects

GWS hits: 22

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified coagulation defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints